Danaher Co. (DHR) Position Decreased by Engineers Gate Manager LP

Engineers Gate Manager LP decreased its stake in Danaher Co. (NYSE:DHR) by 52.0% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 14,851 shares of the conglomerate’s stock after selling 16,111 shares during the quarter. Engineers Gate Manager LP’s holdings in Danaher were worth $1,378,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently added to or reduced their stakes in the stock. GQG Partners LLC purchased a new stake in Danaher in the 2nd quarter worth about $101,000. Zions Bancorporation lifted its stake in Danaher by 118.3% in the 3rd quarter. Zions Bancorporation now owns 1,231 shares of the conglomerate’s stock worth $106,000 after acquiring an additional 667 shares in the last quarter. Patten Group Inc. lifted its stake in Danaher by 262.3% in the 3rd quarter. Patten Group Inc. now owns 4,830 shares of the conglomerate’s stock worth $114,000 after acquiring an additional 3,497 shares in the last quarter. First Personal Financial Services lifted its stake in Danaher by 128.9% in the 4th quarter. First Personal Financial Services now owns 1,227 shares of the conglomerate’s stock worth $114,000 after acquiring an additional 691 shares in the last quarter. Finally, Monetary Management Group Inc. lifted its stake in Danaher by 10.7% in the 2nd quarter. Monetary Management Group Inc. now owns 1,550 shares of the conglomerate’s stock worth $131,000 after acquiring an additional 150 shares in the last quarter. Institutional investors and hedge funds own 76.19% of the company’s stock.

Shares of Danaher Co. (NYSE DHR) opened at $94.46 on Friday. Danaher Co. has a one year low of $78.97 and a one year high of $104.82. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.05 and a current ratio of 1.43. The firm has a market capitalization of $64,198.66, a PE ratio of 22.87, a PEG ratio of 1.94 and a beta of 1.04.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, January 30th. The conglomerate reported $1.19 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.16 by $0.03. Danaher had a return on equity of 11.36% and a net margin of 13.60%. The company had revenue of $5.09 billion during the quarter, compared to the consensus estimate of $4.97 billion. During the same period last year, the business earned $1.05 EPS. The business’s quarterly revenue was up 10.9% on a year-over-year basis. equities research analysts anticipate that Danaher Co. will post 4.37 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 26th. Stockholders of record on Friday, December 29th were issued a dividend of $0.14 per share. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.59%. The ex-dividend date was Thursday, December 28th. Danaher’s dividend payout ratio is 15.86%.

Several equities research analysts recently issued reports on DHR shares. Citigroup increased their price objective on Danaher to $107.00 and gave the stock a “buy” rating in a research note on Friday, December 15th. Robert W. Baird reissued a “buy” rating on shares of Danaher in a research note on Friday, January 12th. Royal Bank of Canada reissued a “hold” rating and issued a $96.00 price objective on shares of Danaher in a research note on Thursday, January 4th. Stifel Nicolaus increased their price objective on Danaher from $110.00 to $115.00 and gave the stock a “buy” rating in a research note on Wednesday, January 31st. Finally, Credit Suisse Group increased their price objective on Danaher from $93.00 to $96.00 and gave the stock an “outperform” rating in a research note on Friday, October 20th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $100.13.

In other news, CFO Daniel L. Comas sold 62,989 shares of the stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $101.96, for a total transaction of $6,422,358.44. Following the transaction, the chief financial officer now owns 227,805 shares of the company’s stock, valued at approximately $23,226,997.80. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Angela S. Lalor sold 42,988 shares of the stock in a transaction dated Friday, February 2nd. The shares were sold at an average price of $102.29, for a total value of $4,397,242.52. Following the transaction, the senior vice president now directly owns 82,008 shares in the company, valued at approximately $8,388,598.32. The disclosure for this sale can be found here. In the last three months, insiders have sold 274,913 shares of company stock worth $27,729,293. 12.20% of the stock is currently owned by insiders.

COPYRIGHT VIOLATION WARNING: This news story was originally published by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark law. The correct version of this news story can be viewed at https://sportsperspectives.com/2018/02/10/danaher-co-dhr-position-decreased-by-engineers-gate-manager-lp.html.

About Danaher

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply